Thrombotic Thrombocytopenic Purpura (TTP!)

123456789
Across
  1. 4. Routinely administered in TTP management to suppress autoimmune production of anti-ADAMTS13 antibodies)
  2. 6. Type of anaemia caused by TTP
  3. 8. An anti-CD20 monoclonal antibody recommended in cases with suboptimal response to first line, or in for those at high risk of relapse
  4. 9. As the problem is in the small vessels, TTP is a?
Down
  1. 1. Mainstay of treatment (2 words)
  2. 2. The nature of neurological manifestations in TTP (come and go)
  3. 3. A haematological condition which overlaps with TTP
  4. 5. Develop in the small vessels in TTP
  5. 7. A metalloprotease enzyme, of which there is a deficiency in TTP